Higher Body Mass Index Predicts Cardiac Autonomic Dysfunction: A Longitudinal Study in Adolescent Type 1 Diabetes
Overview
Pediatrics
Affiliations
Background: Obesity is associated with an increased risk of cardiovascular morbidity in adults with diabetes.
Objective: To examine the predictive role of body mass index (BMI) and adiposity on cardiac autonomic function in childhood onset type 1 diabetes.
Subjects: Two hundred and fifty-three participants with type 1 diabetes (aged 8-30 years) were assessed for diabetes complications at a tertiary hospital, and followed over 7 years (total 922 visits).
Methods: Heart rate variability (HRV) measures assessed by 10-minute electrocardiography recording using LabChart Pro were standard deviation of RR intervals, time between consecutive QRS complexes, [SDNN], root mean squared difference of successive RR intervals (RMSSD), triangular index (TI), and low to high frequency ratio [LF:HF]. Multivariable generalized estimating equations were used to model the longitudinal associations between HRV measures and clinical variables (BMI standard deviation scores [SDS], waist:height ratio, total daily insulin dose/kg (TDD) and hemoglobin A1c [HbA1c]).
Results: At baseline, mean age was 14.4 ± 2.7 years, diabetes duration 7.1 ± 3.7 years, HbA1c 8.3% ± 1.5% (67 ± 16 mmol/mol), and 33% were overweight/obese (BMI ≥85th percentile). At final visit, mean age was 18.5 ± 2.7 years, duration 11.3 ± 3.9 years, HbA1c 9.0% ± 1.8% (75 ± 20 mmol/mol), and 40% were overweight/obese. Adiposity (higher BMI SDS or waist: height ratio) was a significant predictor of worse HRV (lower SDNN, RMSSD; P < .05), while higher HbA1c and TDD predicted all adverse HRV measures (lower SDNN, RMSSD, TI; P < .05) and abnormal sympathovagal balance (higher LF:HF ratio; P < .05).
Conclusions: Higher BMI and central adiposity are associated with cardiac autonomic dysfunction in childhood onset type 1 diabetes, after adjusting for HbA1c. Interventions targeting overweight/obesity during adolescence may optimize long-term vascular health in type 1 diabetes.
Huang X, Bao Y, Wang J, Tian L Rev Cardiovasc Med. 2024; 25(7):244.
PMID: 39139439 PMC: 11317325. DOI: 10.31083/j.rcm2507244.
Binu A, Srinath S, Cherian K, Jacob J, Paul T, Kapoor N Med Sci (Basel). 2022; 10(4).
PMID: 36278526 PMC: 9589960. DOI: 10.3390/medsci10040056.
Varley B, Gow M, Cho Y, Benitez-Aguirre P, Cusumano J, Pryke A Pediatr Diabetes. 2022; 23(7):1073-1079.
PMID: 35856852 PMC: 9805172. DOI: 10.1111/pedi.13393.
Tsubokawa M, Nishimura M, Tamada Y, Nakaji S Healthcare (Basel). 2022; 10(5).
PMID: 35627930 PMC: 9141757. DOI: 10.3390/healthcare10050793.
Franceschi R, Mozzillo E, Candia F, Rosanio F, Leonardi L, Liguori A Acta Diabetol. 2022; 59(3):293-308.
PMID: 35089443 DOI: 10.1007/s00592-022-01850-x.